Skip to main content
FinSpry Logo
FinSpry
NYXH logo
NYXH
(NASDAQ)
Nyxoah SA
$1.47-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nyxoah SA (NYXH) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Nyxoah SA
NYXH•Nasdaq Stock Market•Healthcare•Medical Instruments & Supplies

About Nyxoah SA

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitewww.nyxoah.com
Phone32 1 045 90 75
Address
Rue Edouard Belin 12 Mont-Saint-Guibert, 1435 Belgium

Corporate Identifiers

CIK0001857190
ISINBE0974358906
SIC3841

Leadership Team & Key Executives

Olivier Taelman
Chief Executive Officer and Executive Director
Robert Taub MBA
Co-Founder and Chairman
Bruno Onkelinx
Chief Technical Officer
John Landry
Chief Financial Officer
Jeyakumar Subbaroyan
Chief Science Officer
Pearson Dennis
Investor Relations Associate
An Moonen
General Counsel
Geeta Kaveti
Chief Compliance Officer
Maggie McGowan
Chief Human Resources Officer
Loic Moreau
President of International